Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir-based regimen versus raltegravir-based regimen plus atorvastatin for reducing inflammaging in HIV-infected patients older than 60 years
2015-002682-30Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of raltegravir in human immunodeficiency virus infection (HIV) and inflammaging (3 arms), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: Change in IL-6 levels. Started Jul 2015; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)inflammaging
Beyond the preview
Go deeper on 2015-002682-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002682-30.